Magnesium sulfate IV
A product-specific IV electrolyte/drug label, not a wellness-cocktail recommendation.
FDA-approved product context
A product-specific IV electrolyte/drug label, not a wellness-cocktail recommendation.
Reviewed October 10, 2026. Product and route distinctions stay attached to the source; this is not a treatment recommendation.
Evidence and source limits
The retrieved magnesium sulfate in dextrose label describes intravenous use and specific clinical management such as pre-eclampsia/eclampsia. Its marketing table identifies ANDA206486.
Renal elimination, magnesium toxicity and prolonged-pregnancy fetal risks are important labeled limits. Professional monitoring is needed; this page supplies no infusion or electrolyte-replacement instructions.
Approval applies to the specific labeled product, route and indication, not every preparation of this ingredient or a wellness mixture. Read the original full label and discuss individual circumstances with a medical professional. No dosing or preparation instructions are included.
Original source: Magnesium sulfate IV ↗
Interpretation is limited to the source linked above. Educational source review, not independent medical review. No dosing, preparation instructions, seller links or treatment endorsement.